Rotavirus vaccine effectiveness against the risk of hospitalization and the impact of public expense for the vaccine on a regional rotavirus gastroenteritis epidemic in Japan.
An epidemic of rotavirus (RV) gastroenteritis occurred from April to July 2015 across a wide area of Hokkaido surrounding Abashiri-Kosei General Hospital. The RV vaccine for children in Shari and Koshimizu was provided at public expense by their local governments, while children in Abashiri were charged for the vaccine. This study examined the RV vaccine effectiveness against risk of hospitalization based on a retrospective cohort study and the impact of public expense for the RV vaccine on this regional RV gastroenteritis epidemic. The vaccination coverage was significantly higher in children in Shari and Koshimizu than in Abashiri (87.8% vs. 42.7%, respectively, p<0.001). The RV gastroenteritis-related risk of hospitalization was slightly lower in children in Shari and Koshimizu than in Abashiri (1.6% vs. 3.2%, respectively, p=0.07). In addition, the risk of hospitalization in the vaccinated children was significantly lower than in the unvaccinated children (0.7% vs. 4.8%, respectively, p<0.001); indicating the RV vaccine effectiveness against the risk of hospitalization was 96.5 % (95%CI 45.7-99.8%). In conclusion, the public expense for the RV vaccine increased the vaccination coverage, which, in combination with high vaccine effectiveness, led to a decrease in the number of hospitalized children during a regional RV gastroenteritis epidemic.